COVAX-19
Vaccine candidate against COVID-19 / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about COVAX-19?
Summarize this article for a 10 year old
SHOW ALL QUESTIONS
COVAX-19 (or SpikoGen) is a recombinant protein-based COVID-19 vaccine developed by South Australian-based biotech company Vaxine, in collaboration with CinnaGen, a private company with operations in the Middle East. It is under clinical trial in collaboration with the Iranian company CinnaGen.[2][3][4]
You can help expand this article with text translated from the corresponding article in Persian. (January 2022) Click [show] for important translation instructions.
|
Quick Facts Vaccine description, Target ...
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Protein subunit |
Clinical data | |
Trade names | Spikogen[1] |
Routes of administration | Intramuscular |
Legal status | |
Legal status |
|
Close